DOI: http://dx.doi.org/10.18203/2349-3933.ijam20201107

Study of thyroid dysfunction in metabolic syndrome in patients of Amalapuram, Andhra Pradesh, India

Ranjith Vara, Arugolanu Prudhvi Raj, Pravin Gulab Rao Maske

Abstract


Background: Both metabolic syndrome and thyroid dysfunction are associated with increased risk of atherosclerotic heart disease. The present study was conducted to study the Association of thyroid dysfunction and Metabolic syndrome and to find out the type of thyroid dysfunction in metabolic syndrome patients.

Methods: Sixty cases were defined according to the IDF Criteria. Detailed history and necessary investigations like fasting blood sample was analyzed for total triiodothyronine (T3), total thyroxine (T4), thyroid-stimulating hormone (TSH), lipid profile, and blood glucose were undertaken.

Results: In this study population of metabolic syndrome cases, the thyroid dysfunction is present in 16.7% patients. Among the thyroid dysfunction, sub clinical hypothyroidism is highly prevalent - 11.7%, The hypothyroidism is 3.3% prevalent in metabolic syndrome patients (one patient had TSH levels of more than 150 mU/L) and sub clinical hyperthyroidism is 1.7% prevalent. There were no overt hyperthyroidism patients in the study.

Conclusions: This study clearly shows that, one sixth of metabolic syndrome patients or every sixth metabolic syndrome had hypothyroidism either overt or subclinical. This finding indicates a need for investigating the presence of Thyroid dysfunction during managing metabolic syndrome patients

Keywords


Correlation, Hyperlipidemia, Metabolic syndrome, Subclinical hypothyroidism, Thyroid dysfunction

Full Text:

PDF

References


Reaven GM. Role of insulin resistance in human disease. Diab. 1988 Dec 1;37(12):1595-607.

Reaven GM. Insulin resistance, cardiovascular disease, and the metabolic syndrome: how well do the emperor’s clothes fit?. Diab Care. 2004 Apr 1;27(4):1011-2.

Grundy GM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinal Metab. 2004;89:2595-600.

Zimmet PZ. The metabolic syndrome. Lancet 2005:365:1415-28.

Klein I, Ojamaa K. Thyroid hormones and cardiovascular system. N Engl J Med. 1976;344:501-9.

Duntas LH. Thyroid disease and lipids. Thyroid. 2002 Apr 1;12(4):287-93.

Uzunlulu M, Yorulmaz E, Oguz A. Prevalence of subclinical hypothyroidism in patients with metabolic syndrome. Endo J. 2007;54(1):71-6.

Shrestha S, Das BK, Baral N, Chandra L. Association of metabolic syndrome and its components with thyroid dysfunction in females. Int J Diab Dev Ctries. 2007 Mar;27(1):25.

Lin SY, Wang YY, Liu PH, Lai WA, Sheu WH. Lower serum free thyroxine levels are associated with metabolic syndrome in a Chinese population. Metab. 2005 Nov 1;54(11):1524-8.

Gyawali P, Takanche JS, Shrestha RK, Bhattarai P, Khanal K, Risal P, et al. Pattern of thyroid dysfunction in patients with metabolic syndrome and its relationship with components of metabolic syndrome. Diab Metab J. 2015 Feb 1;39(1):66-73.

Shantha GP, Kumar AA, Jeyachandran V, Rajamanickam D, Rajkumar K, Salim S, et al. Association between primary hypothyroidism and metabolic syndrome and the role of C reactive protein: a cross–sectional study from South India. Thyroid Res. 2009 Dec;2(1):2.

Khatiwada S, Sah SK, Rajendra KC, Baral N, Lamsal M. Thyroid dysfunction in metabolic syndrome patients and its relationship with components of metabolic syndrome. Clini Diab Endocrinol. 2016 Dec;2(1):3.

Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004 Jan 14;291(2):228-38.

Mehran L, Amouzegar A, Rahimabad PK, Tohidi M, Tahmasebinejad Z, Azizi F. Thyroid function and metabolic syndrome: a population-based thyroid study. Hormone Metab Res. 2017;49(03):192-200.